In line with this, deregulation of CDKs are common hallmarks in cell-cycle alterations found in tumors (Dickson 2014), and CDK4/6 has a pivotal role in the G1-to-S-phase cell-cycle transition in cancer (O’Leary et al. 2016). This evidence concerns the gene CDK4 and cancer.